NCT03324113 2025-08-05Evaluation of SAR408701 in Japanese Patients With Advanced Malignant Solid TumorsSanofiPhase 1 Completed34 enrolled
NCT02648490 2019-07-30An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of HLX07,in Patients With Advanced Solid CancersHenlix, IncPhase 1 Completed19 enrolled